Cytiva

Cytiva and BioCentriq, a New Jersey-based cell and gene therapy contract development and manufacturing organisation (CDMO), have been awarded funding from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a public-private partnership whose mission is to accelerate biopharmaceutical innovation.  Viral clearance is a key regulatory requirement for all biopharmaceutical processes but is a relatively […]

Culture Biosciences and Cytiva are collaborating to advance innovation in upstream bioprocessing by providing customers greater access to predictive and robust scale-up capabilities.   Together, the companies aim to bring new bioprocess solutions to customers that use digitaliation, in-silico approaches, and virtual monitoring and control of experiments.  As the first step in this new collaboration, Cytiva’s […]

Several new products for the life sciences sector have been launched over the last month, from miniature semiconductor chip (MSC) technology to a new inhalation testing service. DDW provides an update. GenScript Biotech Corporation: GenTitan Gene Fragments Synthesis service Powered by GenScript’s miniature semiconductor chip (MSC) technology, GenTitan gives scientists access to high-throughput, synthetic DNA, […]

Cytiva and the life sciences business of Pall Corporation have completed their integration and are now united as one business under the Cytiva brand. In January 2023, the life sciences business of Pall separated from Pall Corporation. Pall’s biotech portfolio is now a product family in Cytiva’s bioprocess business. The Pall medical portfolio will remain […]

This article is sponsored by Cytiva. The new PrismA ELISA kit is an enzyme-linked immunosorbent assay designed to measure residual ligand leakage when using MabSelect PrismA chromatography resin and Fibro PrismA chromatography adsorbers. The kit is used during the development and manufacture of monoclonal antibody (mAb) biopharmaceuticals.  This kit is the only commercial ELISA kit […]

Life sciences organisation Cytiva has acquired a new facility in Michigan US to help it expand its resins manufacturing operations outside of Sweden.   The company’s new chromatography resins manufacturing site will be based in Muskegon, Michigan and forms part of Cytiva and Pall Corporation’s $1.5 billion capacity expansion investment.  Cytiva plans to transform the site […]

Cytiva offer solutions to support work from biological research to clinical therapy, including tools for research, drug discovery, diagnostics and bioprocessing. Ryan Walker, the Sustainability Program Leader at Cytiva, discussed with DDW’s Megan Thomas the steps Cytiva is making to make their vision of a more sustainable future a reality.  When asked how easy it […]